LLY

934.61

-1.88%↓

JNJ

186.19

+0.07%↑

UNH

324.08

-1.1%↓

NVS

126.35

+0.57%↑

ABT

124.59

+0.18%↑

LLY

934.61

-1.88%↓

JNJ

186.19

+0.07%↑

UNH

324.08

-1.1%↓

NVS

126.35

+0.57%↑

ABT

124.59

+0.18%↑

LLY

934.61

-1.88%↓

JNJ

186.19

+0.07%↑

UNH

324.08

-1.1%↓

NVS

126.35

+0.57%↑

ABT

124.59

+0.18%↑

LLY

934.61

-1.88%↓

JNJ

186.19

+0.07%↑

UNH

324.08

-1.1%↓

NVS

126.35

+0.57%↑

ABT

124.59

+0.18%↑

LLY

934.61

-1.88%↓

JNJ

186.19

+0.07%↑

UNH

324.08

-1.1%↓

NVS

126.35

+0.57%↑

ABT

124.59

+0.18%↑

Home・Elenco Azioni・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Aperta

6.07

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

5.93

Massimo

6.43

Metriche Chiave
By Trading Economics
Entrata	-1.5M -17M
Vendite	-5.2M 47M
Margine di Profitto	-36.715
Dipendenti	477
EBITDA	-1.4M -14M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+29.14% upside

Dividendi
By Dow Jones
Utili prossimi	6 nov 2025

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	63M 416M
Apertura precedente	6.07
Chiusura precedente	6.07

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

7.16 / 7.65 Supporto e resistenza

Treace Medical Concepts Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 nov 2025, 23:51 UTC

Utili

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 nov 2025, 23:10 UTC

Utili

DBS Third Quarter Net Dips 2.0%

5 nov 2025, 22:55 UTC

Utili

Arm Holdings 2Q Profit Climbs on Record Demand

5 nov 2025, 22:23 UTC

Utili

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 nov 2025, 23:52 UTC

Utili

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 nov 2025, 23:49 UTC

Utili

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 nov 2025, 23:49 UTC

Utili

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 nov 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 nov 2025, 23:42 UTC

Discorsi di Mercato

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 nov 2025, 23:12 UTC

Utili

Nutrien 3Q Adj EPS 97c >NTR.T

5 nov 2025, 23:11 UTC

Utili

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 nov 2025, 23:10 UTC

Utili

Nutrien 3Q Sales $6.01B >NTR.T

5 nov 2025, 23:10 UTC

Discorsi di Mercato

Utili

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 nov 2025, 23:10 UTC

Utili

Nutrien 3Q EPS 96c >NTR.T

5 nov 2025, 23:04 UTC

Utili

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 nov 2025, 23:03 UTC

Discorsi di Mercato

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 nov 2025, 22:55 UTC

Discorsi di Mercato

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 nov 2025, 22:55 UTC

Utili

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 nov 2025, 22:51 UTC

Utili

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 nov 2025, 22:50 UTC

Utili

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 nov 2025, 22:44 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov 2025, 22:43 UTC

Discorsi di Mercato

Utili

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 nov 2025, 22:36 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

5 nov 2025, 22:36 UTC

Discorsi di Mercato

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 nov 2025, 22:20 UTC

Discorsi di Mercato

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 nov 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Responds to Delaware Chancery Court Ruling

5 nov 2025, 22:01 UTC

Utili

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 nov 2025, 22:01 UTC

Utili

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Confronto tra pari

Modifica del prezzo

Treace Medical Concepts Inc Previsione

Obiettivo di Prezzo

By TipRanks

29.14% in crescita

Previsioni per 12 mesi

Media 8.42 USD 29.14%

Alto 12 USD

Basso 6 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 6 che hanno fornito valutazioni azionarie a Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

7.16 / 7.65Supporto e resistenza

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.